LIUZHOU CITY, China, March 3 /PRNewswire-Asia/ -- China Baicaotang Medicine Limited, , ("China Baicaotang" or the "Company"), the leading pharmaceutical distributor, retail pharmacy, and manufacturer of pharmaceuticals and medical-related products in Guangxi Province, China, today announced that Ms. Shelly Zhang, chief financial officer, and Mr. Huitian Tang, the Chairman and CEO, will present at the upcoming Rodman & Renshaw Annual China Investment Conference in Beijing, China.
The date, time, and location of China Baicaotang's presentation are as follows:
The Rodman & Renshaw Annual China Investment Conference is a three-day event which features tracks devoted to Agriculture, Healthcare, Metals & Mining, Energy, Clean-tech, Asia, Community & Regional Banks, Growth, & Maritime. During the conference, the Company will be available for one-on-one meetings.
About China Baicaotang
China Baicaotang is engaged in pharmaceutical distribution, pharmacy retailing, and the manufacture of pharmaceuticals and medical-related products through its subsidiaries Guangxi Liuzhou Baicaotang Medicine Limited, Hefeng Pharmaceutical Co. Limited, and Guangxi Liuzhou Baicaotang Medicine Retail Limited in Guangxi province, China. It operates the largest regional retail network in Guangxi province, consisting of 66 directly owned retail stores in Guangxi province and currently over 8,000 products are distributed through the Company's wholesale distribution network.
CONTACT: Shelly Zhang, Chief Financial Officer of China Baicaotang
Medicine Limited, +86-772-363-8318, z_shelly@hotmail.com; or Shaun Smolarz,
Financial Writer, +1-646-701-7444, shaun.smolarz@ccgir.com, or Crocker
Coulson, President of CCG Investor Relations, +1-646-213-1915,
crocker.coulson@ccgir.com
